NCT00670930 · Interventional trial
Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists
Overall registry status Completed
Phase 4
Conditions Allergic Asthma
Delaware Valley sites
- Novartis Investigative Site · Philadelphia, PA · Philadelphia County
- Novartis Investigative Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory